FDA issues second EUA for antibody treatment for COVID November 21, 2020 sbracken The FDA has granted Emergency Use Authorization (EUA) to Regeneron Pharmaceuticals for casirivimab and imdevimab, administered together, as a treatment for COVID-19. This is... Read More